143 related articles for article (PubMed ID: 11730749)
1. Prophylactic methotrexate after linear salpingostomy: a decision analysis.
Gracia CR; Brown HA; Barnhart KT
Fertil Steril; 2001 Dec; 76(6):1191-5. PubMed ID: 11730749
[TBL] [Abstract][Full Text] [Related]
2. Interventions for tubal ectopic pregnancy.
Hajenius PJ; Mol F; Mol BW; Bossuyt PM; Ankum WM; van der Veen F
Cochrane Database Syst Rev; 2007 Jan; 2007(1):CD000324. PubMed ID: 17253448
[TBL] [Abstract][Full Text] [Related]
3. Disparities in the management of ectopic pregnancy.
Hsu JY; Chen L; Gumer AR; Tergas AI; Hou JY; Burke WM; Ananth CV; Hershman DL; Wright JD
Am J Obstet Gynecol; 2017 Jul; 217(1):49.e1-49.e10. PubMed ID: 28288792
[TBL] [Abstract][Full Text] [Related]
4. Intratubal methotrexate for prevention of persistent ectopic pregnancy after salpingotomy.
Kaya H; Babar Y; Ozmen S; Ozkaya O; Karci M; Aydin AR; Ozbasar D
J Am Assoc Gynecol Laparosc; 2002 Nov; 9(4):464-7. PubMed ID: 12386357
[TBL] [Abstract][Full Text] [Related]
5. Fertility outcomes subsequent to treatment of tubal ectopic pregnancy in younger Turkish women.
Turan V
J Pediatr Adolesc Gynecol; 2011 Oct; 24(5):251-5. PubMed ID: 21715197
[TBL] [Abstract][Full Text] [Related]
6. Fertility outcome after systemic methotrexate and laparoscopic salpingostomy for tubal pregnancy.
Dias Pereira G; Hajenius PJ; Mol BW; Ankum WM; Hemrika DJ; Bossuyt PM; van der Veen F
Lancet; 1999 Feb; 353(9154):724-5. PubMed ID: 10073522
[No Abstract] [Full Text] [Related]
7. Severe intra-abdominal bleeding from neglected omental implantation of ectopic tissue after methotrexate treatment for persistent ectopic pregnancy.
Wu MC; Huang WC; Lin HH; Hsiao SM
Fertil Steril; 2011 Jun; 95(7):2435.e1-3. PubMed ID: 21334612
[TBL] [Abstract][Full Text] [Related]
8. Ectopic pregnancy; risk factors and comparison of intervention success rates in tubal ectopic pregnancy.
Kazandi M; Turan V
Clin Exp Obstet Gynecol; 2011; 38(1):67-70. PubMed ID: 21485731
[TBL] [Abstract][Full Text] [Related]
9. Current evidence on surgery, systemic methotrexate and expectant management in the treatment of tubal ectopic pregnancy: a systematic review and meta-analysis.
Mol F; Mol BW; Ankum WM; van der Veen F; Hajenius PJ
Hum Reprod Update; 2008; 14(4):309-19. PubMed ID: 18522946
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate prophylaxis for persistent ectopic pregnancy after conservative treatment by salpingostomy.
Graczykowski JW; Mishell DR
Obstet Gynecol; 1997 Jan; 89(1):118-22. PubMed ID: 8990451
[TBL] [Abstract][Full Text] [Related]
11. Treatment for repeat tubal ectopic pregnancy.
Cobellis L; De Lucia E
Int J Gynaecol Obstet; 2000 Jan; 68(1):47-8. PubMed ID: 10687837
[No Abstract] [Full Text] [Related]
12. Systemic methotrexate therapy versus laparoscopic salpingostomy in tubal pregnancy. Part II. Patient preferences for systemic methotrexate.
Nieuwkerk PT; Hajenius PJ; Van der Veen F; Ankum WM; Wijker W; Bossuyt PM
Fertil Steril; 1998 Sep; 70(3):518-22. PubMed ID: 9757882
[TBL] [Abstract][Full Text] [Related]
13. Methotrexate as a possible cause of ovarian cysts formation: experience with women treated for ectopic pregnancies.
Ben-Shlomo I; Eliyahu S; Yanai N; Shalev E
Fertil Steril; 1997 Apr; 67(4):786-8. PubMed ID: 9093213
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of presumptively medically treating women at risk for ectopic pregnancy compared with first performing a dilatation and curettage.
Ailawadi M; Lorch SA; Barnhart KT
Fertil Steril; 2005 Feb; 83(2):376-82. PubMed ID: 15705378
[TBL] [Abstract][Full Text] [Related]
15. Characterizing ectopic pregnancies that rupture despite treatment with methotrexate.
Dudley PS; Heard MJ; Sangi-Haghpeykar H; Carson SA; Buster JE
Fertil Steril; 2004 Nov; 82(5):1374-8. PubMed ID: 15533363
[TBL] [Abstract][Full Text] [Related]
16. The ESEP study: salpingostomy versus salpingectomy for tubal ectopic pregnancy; the impact on future fertility: a randomised controlled trial.
Mol F; Strandell A; Jurkovic D; Yalcinkaya T; Verhoeve HR; Koks CA; van der Linden PJ; Graziosi GC; Thurkow AL; Hoek A; Hogström L; Klinte I; Nilsson K; van Mello NM; Ankum WM; van der Veen F; Mol BW; Hajenius PJ;
BMC Womens Health; 2008 Jun; 8():11. PubMed ID: 18582372
[TBL] [Abstract][Full Text] [Related]
17. Systemic methotrexate therapy versus laparoscopic salpingostomy in patients with tubal pregnancy. Part I. Impact on patients' health-related quality of life.
Nieuwkerk PT; Hajenius PJ; Ankum WM; Van der Veen F; Wijker W; Bossuyt PM
Fertil Steril; 1998 Sep; 70(3):511-7. PubMed ID: 9757881
[TBL] [Abstract][Full Text] [Related]
18. Reproductive potential after methotrexate treatment of ectopic gestation in a community hospital.
Tolaymat LL; Brown TL; Maher JE; Horan CA; Green BA; Ripps BA
J Reprod Med; 1999 Apr; 44(4):335-8. PubMed ID: 10319302
[TBL] [Abstract][Full Text] [Related]
19. [Normal pregnancy after laser salpingostomy, blighted ovum, and right tubal pregnancy treated with methotrexate].
Cyrkowicz A; Czekański A; Cyrkowicz A; Kula K
Ginekol Pol; 1999 Jun; 70(6):453-5. PubMed ID: 10895288
[TBL] [Abstract][Full Text] [Related]
20. Fertility outcome following combined methotrexate treatment of unruptured extrauterine pregnancy.
Debby A; Golan A; Sadan O; Zakut H; Glezerman M
BJOG; 2000 May; 107(5):626-30. PubMed ID: 10826577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
